Q3 FY2026 · ended Sep 30, 2026 · Revenue $122.98M, +47.2% YoY · Filed Nov 4, 2026
BillionToOne, Inc. (BLLN) files with the SEC under industry code 8071, Services-Medical Laboratories. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $123.0 million and net income of $17.4 million. Free cash flow was $8.6 million. As of Sep 30, 2026 it held $561.5 million in cash and investments and $140.4 million in total debt.
Revenue
$122.98M
+47.2% vs year-ago quarter
Net income
$17.39M
+204.5% vs year-ago quarter
Operating cash flow
$12.55M
-9.1% vs year-ago quarter
Free cash flow
$8.60M
+33.2% vs year-ago quarter
EPS
$0.32
+220.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
11.18M
Net cash
$421.06M
Q3 FY2026
Operating margin
10.2%
TTM
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BLLN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2070849
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- CareDx, Inc. CDNA
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $123.0M | $109.4M | $108.4M | $96.1M | $83.5M |
| Operating income | $11.0M | $5.5M | $17.8M | $10.3M | $9.6M |
| Net income | $17.4M | $8.1M | $18.0M | $6.0M | $5.7M |
| Diluted EPS | $0.32 | $0.15 | $0.34 | $0.06 | $0.10 |
| Operating cash flow | $12.5M | $9.1M | $15.4M | $10.8M | $13.8M |
| Free cash flow | $8.6M | $5.1M | $11.0M | $9.3M | $6.5M |
| Total assets | $760.5M | $729.7M | $700.7M | $632.7M | $327.5M |
| Total liabilities | $193.9M | $192.9M | $195.1M | $152.5M | $147.6M |
| Stockholders' equity | $566.5M | $536.8M | $505.6M | $480.1M | -$239.5M |
| Cash and investments | $561.5M | $548.6M | $537.5M | $496.0M | $195.2M |
| Total debt | $140.4M | $143.9M | $144.2M | $108.9M | $108.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 29, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 16, 2026 | Jun 10, 2026 |
All 178 BillionToOne, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.